Nanjing Vishee Medical Technology Co Ltd (688580) - Total Assets
Based on the latest financial reports, Nanjing Vishee Medical Technology Co Ltd (688580) holds total assets worth CN¥1.86 Billion CNY (≈ $272.61 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Nanjing Vishee Medical Technology Co Ltd (688580) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Nanjing Vishee Medical Technology Co Ltd - Total Assets Trend (2013–2025)
This chart illustrates how Nanjing Vishee Medical Technology Co Ltd's total assets have evolved over time, based on quarterly financial data. See Nanjing Vishee Medical Technology Co Ltd net assets for net asset value and shareholders' equity analysis.
Nanjing Vishee Medical Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Nanjing Vishee Medical Technology Co Ltd's total assets of CN¥1.86 Billion consist of 58.4% current assets and 41.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 53.6% |
| Accounts Receivable | CN¥17.10 Million | 0.9% |
| Inventory | CN¥42.21 Million | 2.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥130.37 Million | 6.8% |
| Goodwill | CN¥69.31 Million | 3.6% |
Asset Composition Trend (2013–2025)
This chart illustrates how Nanjing Vishee Medical Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 688580 stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nanjing Vishee Medical Technology Co Ltd's current assets represent 58.4% of total assets in 2025, a decrease from 93.4% in 2013.
- Cash Position: Cash and equivalents constituted 53.6% of total assets in 2025, up from 11.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 1.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 6.8% of total assets.
Nanjing Vishee Medical Technology Co Ltd Competitors by Total Assets
Key competitors of Nanjing Vishee Medical Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Insulet Corporation
NASDAQ:PODD
|
USA | $2.99 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRI
|
USA | $1.76 Billion |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Epitomee Medical Ltd
TA:EPIT
|
Israel | ILA37.04 Million |
Nanjing Vishee Medical Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 9.65 | 7.58 | 12.82 |
| Quick Ratio | 9.31 | 7.34 | 12.51 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥925.23 Million | CN¥1.00 Billion | CN¥1.26 Billion |
Nanjing Vishee Medical Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Nanjing Vishee Medical Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.73 |
| Latest Market Cap to Assets Ratio | 0.44 |
| Asset Growth Rate (YoY) | 4.9% |
| Total Assets | CN¥1.91 Billion |
| Market Capitalization | $838.34 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nanjing Vishee Medical Technology Co Ltd's assets below their book value (0.44x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Nanjing Vishee Medical Technology Co Ltd's assets grew by 4.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Nanjing Vishee Medical Technology Co Ltd (2013–2025)
The table below shows the annual total assets of Nanjing Vishee Medical Technology Co Ltd from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.91 Billion ≈ $279.35 Million |
+4.87% |
| 2024-12-31 | CN¥1.82 Billion ≈ $266.38 Million |
+0.79% |
| 2023-12-31 | CN¥1.81 Billion ≈ $264.28 Million |
+7.23% |
| 2022-12-31 | CN¥1.68 Billion ≈ $246.45 Million |
+2.77% |
| 2021-12-31 | CN¥1.64 Billion ≈ $239.80 Million |
+6.38% |
| 2020-12-31 | CN¥1.54 Billion ≈ $225.42 Million |
+281.09% |
| 2019-12-31 | CN¥404.22 Million ≈ $59.15 Million |
+31.09% |
| 2018-12-31 | CN¥308.36 Million ≈ $45.12 Million |
+25.06% |
| 2017-12-31 | CN¥246.57 Million ≈ $36.08 Million |
+45.29% |
| 2016-12-31 | CN¥169.71 Million ≈ $24.83 Million |
+33.90% |
| 2015-12-31 | CN¥126.74 Million ≈ $18.55 Million |
+55.82% |
| 2014-12-31 | CN¥81.34 Million ≈ $11.90 Million |
+13.77% |
| 2013-12-31 | CN¥71.50 Million ≈ $10.46 Million |
-- |
About Nanjing Vishee Medical Technology Co Ltd
Nanjing Vishee Medical Technology Co., Ltd provides rehabilitation meditation products and solutions in China and internationally. The company offers MagNeuro, a transcranial magnetic stimulation (TMS) for use in anxiety disorders, movement disorders, and ADHD applications; MagNeuro ONE, a TMS therapy system with navigation for use in anxiety disorders applications; and MagBelle, a pelvic floor m… Read more